Pacira BioSciences, Inc. delivers innovative, non-opioid pain therapies to transform the lives of patients. Specializing in the development of targeted, locally-administered interventions, Pacira currently has three commercial-stage non-opioid treatments, and is advancing a novel gene therapy asset with the potential to treat large prevalent diseases like osteoarthritis.
For investor relations inquiries, please contact:
Susan Mesco
(973) 451-4030
Susan.Mesco@pacira.com